Paving the road to personalized medicine: Recommendations on regulatory, intellectual property and reimbursement challengesJournal of Law and the Biosciences.

Opportunities and challenges for the cellular immunotherapy sector: A global landscape of clinical trialsRegenerative Medicine. doi: 10.2217/rme-2017-0031

Creating a data resource: What will it take to build a medical information commonsGenome Medicine. doi: 10.1186/s13073-017-0476-3

A blueprint for the next generation of ELSI research, training, and outreach in regenerative medicineRegenerative Medicine. doi: 10.1038/s41536-017-0026-z

Marketing of unproven stem cell–based interventions: A call to actionScience Translational Medicine. doi: 10.1126/scitranslmed.aag0426

The sIRB system: A single beacon of progress in the revised Common Rule? The American Journal of Bioethics

The ethics of genome editing in the clinic: A dose of realism for healthcare leadersHealthcare Management Forum 

More haste, less speed: Could public private partnerships advance cellular immunotherapies? Frontiers in Medicine. doi: 10.3389/fmed.2017.00134

Responsible translation of stem cell research: An assessment of clinical trial registration and publicationsStem Cell Reports

Discounting the recommendations of the second panel on cost-effectiveness in health and medicinePharmacoEconomicsdoi: 10.1007/s40273-016-0482-0

Non-invasive prenatal testing and the unveiling of an impaired translation processJournal of Obstetrics and Gynaecology Canadadoi: 10.1016/j.jogc.2016.09.004

Consider drug efficacy before first-in-human trialsNature. doi: 10.1038/542025a

Show drugs work before selling themNature. doi: 10.1038/543174a

The health economics for regenerative medicine: How payers think and what that means for developers (book chapter). “Mesenchymal Stromal Cells: Translational Pathways to Clinical Adoption.”

Determinants of change in the cost-effectiveness thresholdMedical Decision Making


Streamlining ethical review of data intensive researchBMJ.

How mutually recognizable is mutual recognition? An international terminology index of research ethics review policies in the USA, Canada, UK and AustraliaPersonalized Medicine.

Ethics review for international data-intensive researchScience.